Connexin 43 is involved in aldosterone-induced podocyte injury

Cellular Physiology and Biochemistry

Volumn 34, Issue 5, 2014, Pages 1652-1662

  Yang, Min ^a   Wang, Bin ^a   Li, Min ^a   Jiang, Bo ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Aldosterone; Apoptosis; Connexin 43; Podocytes; ROS

Indexed keywords

ALDOSTERONE; CONNEXIN 43; CREATININE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; WT1 PROTEIN; CONNEXIN 43 PROTEIN, RAT; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL DAMAGE; CELL DIFFERENTIATION; CONTROLLED STUDY; CREATININE CLEARANCE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GAP JUNCTION; GENE EXPRESSION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; NICK END LABELING; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT; TUNEL ASSAY;

RATTUS;

ALDOSTERONE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL COMMUNICATION; CELLS, CULTURED; CONNEXIN 43; GAP JUNCTIONS; IN SITU NICK-END LABELING; MALE; MEMBRANE PROTEINS; PODOCYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; UP-REGULATION;

EID: 84911489012     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366367     Document Type: Article

References (37)

1. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307.
2. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131-2147.
3. Su M, Dhoopun AR, Yuan Y, Huang S, Zhu C, Ding G, Liu B, Yang T, Zhang A: Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury. Am J Physiol Renal Physiol 2013;305:F520-F531.
4. Yuan Y, Huang S, Wang W, Wang Y, Zhang P, Zhu C, Ding G, Liu B, Yang T, Zhang A: Activation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Kidney Int 2012;82:771-789.
5. Yogi A, Callera GE, O'Connor SE, He Y, Correa JW, Tostes RC, Mazur A, Touyz RM: Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. J Hypertens 2011;29:1400-1410.
6. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T: Podocyte as the target for aldosterone: Roles of oxidative stress and Sgk1. Hypertension 2007;49:355-364.
7. Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, Sulkowska M: Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 2006;59:429-433.
8. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC: Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 2003;83:1359-1400.
9. Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J: Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol 2010;298:R1143-R1155.
10. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G: Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;383:725-737.
11. Arendshorst WJ: Connexin 40 mediates tubuloglomerular feedback paracrine signaling by coupling tubular and vascular cells in the renal juxtaglomerular apparatus. Am J Physiol Renal Physiol 2012;303:F1409-F1411.
12. Sorensen CM, Holstein-Rathlou NH: Cell-cell communication in the kidney microcirculation. Microcirculation 2012;19:451-460.
13. Sawai K, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Yoshioka T, Takeda R, Sugawara A, Kuwahara T, Saleem MA, Ogawa O, Nakao K: Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. Nephrol Dial Transplant 2006;21:2472-2477.
14. Just A, Kurtz L, de Wit C, Wagner C, Kurtz A, Arendshorst WJ: Connexin 40 mediates the tubuloglomerular feedback contribution to renal blood flow autoregulation. J Am Soc Nephrol 2009;20:1577-1585.
15. Yaoita E, Yao J, Yoshida Y, Morioka T, Nameta M, Takata T, Kamiie J, Fujinaka H, Oite T, Yamamoto T: Upregulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol 2002;161:1597-1606.
16. Yan Q, Gao K, Chi Y, Li K, Zhu Y, Wan Y, Sun W, Matsue H, Kitamura M, Yao J: NADPH oxidase-mediated upregulation of connexin43 contributes to podocyte injury. Free Radic Biol Med 2012;53:1286-1297.
17. Katsuya K, Yaoita E, Yoshida Y, Yamamoto Y, Yamamoto T: An improved method for primary culture of rat podocytes. Kidney Int 2006;69:2101-2106.
18. Mundel P, Reiser J, Zuniga M B A, Pavenstadt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997;236:248-258.
19. Ding W, Yang L, Zhang M, Gu Y: Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells. Biochem Biophys Res Commun 2012;418:451-456.
20. Sato T, Haimovici R, Kao R, Li AF, Roy S: Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes 2002;51:1565-1571.
21. Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L: Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 2001;133:687-694.
22. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG: Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003;63:1791-1800.
23. Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB: Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol 2005;16:3306-3314.
24. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
25. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
26. Mathew JT, Patni H, Chaudhary AN, Liang W, Gupta A, Chander PN, Ding G, Singhal PC: Aldosterone induces mesangial cell apoptosis both in vivo and in vitro. Am J Physiol Renal Physiol 2008;295:F73-F81.
27. Patni H, Mathew JT, Luan L, Franki N, Chander PN, Singhal PC: Aldosterone promotes proximal tubular cell apoptosis: Role of oxidative stress. Am J Physiol Renal Physiol 2007;293:F1065-F1071.
28. Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T: Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006;47:1084-1093.
29. Nagase M, Fujita T: Aldosterone and glomerular podocyte injury. Clin Exp Nephrol 2008;12:233-242.
30. Haefliger JA, Demotz S, Braissant O, Suter E, Waeber B, Nicod P, Meda P: Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. Kidney Int 2001;60:190-201.
31. Chen S, Meng XF, Zhang C: Role of NADPH oxidase-mediated reactive oxygen species in podocyte injury. Biomed Res Int 2013;2013:839761.
32. Abais JM, Xia M, Li G, Gehr TW, Boini KM, Li PL: Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia. Free Radic Biol Med 2014;67:211-220.
33. Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, Kimura S, Yukimura T, Kiyomoto H, Kohno M, Abe Y, Nishiyama A: Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 2005;16:2906-2912.
34. Plotnikov EY, Kazachenko AV, Vyssokikh MY, Vasileva AK, Tcvirkun DV, Isaev NK, Kirpatovsky VI, Zorov DB: The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int 2007;72:1493-1502.
35. Adams JM, Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001;26:61-66.
36. Reed JC: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995;7:541-546.
37. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-336.